Skip to main
GL

GL Stock Forecast & Price Target

GL Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 56%
Hold 22%
Sell 0%
Strong Sell 0%

Bulls say

Globe Life Inc. demonstrates a robust growth trajectory, with expected life premium growth targeted at 4.0%-4.5% and health premium projected to rise by 14%-16% in the upcoming year, indicating strong demand for their products. The company's strategic marketing efforts are anticipated to yield a 10% increase in leads generated for exclusive agencies, supporting sustained sales momentum across its operational segments. Additionally, favorable mortality experience and adjustments yielded a total remeasurement gain of $150 million in Q3, reflecting the strength of Globe Life's underwriting and financial health, which underpins its long-term growth outlook.

Bears say

Globe Life Inc. has projected minimal growth in operating earnings per share for 2026, with a midpoint estimate of $14.60-$15.30 reflecting only 3% growth, primarily due to significant assumption updates impacting profitability. Additionally, the anticipated decline in Life remeasurement gains, forecasted at $50-$100 million compared to $192 million from the previous year, raises concerns about the sustainability of the company's earnings. Compounding this negative outlook are operational risks, including potential fines from an EEOC review, increased health utilization leading to margin pressure, and challenges in salesforce recruiting that could adversely affect revenue growth.

GL has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 56% recommend Buy, 22% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Globe Life Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Globe Life Inc (GL) Forecast

Analysts have given GL a Buy based on their latest research and market trends.

According to 9 analysts, GL has a Buy consensus rating as of Mar 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $169.22, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $169.22, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Globe Life Inc (GL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.